These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 23740978)
21. The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus. Abente EJ; Santos J; Lewis NS; Gauger PC; Stratton J; Skepner E; Anderson TK; Rajao DS; Perez DR; Vincent AL J Virol; 2016 Sep; 90(18):8266-80. PubMed ID: 27384658 [TBL] [Abstract][Full Text] [Related]
23. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties. Strengell M; Ikonen N; Ziegler T; Julkunen I PLoS One; 2011; 6(10):e25848. PubMed ID: 22022458 [TBL] [Abstract][Full Text] [Related]
24. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication. Östbye H; Gao J; Martinez MR; Wang H; de Gier JW; Daniels R J Virol; 2020 Sep; 94(19):. PubMed ID: 32699088 [TBL] [Abstract][Full Text] [Related]
25. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response. Zhao D; Liang L; Wang S; Nakao T; Li Y; Liu L; Guan Y; Fukuyama S; Bu Z; Kawaoka Y; Chen H J Virol; 2017 Apr; 91(7):. PubMed ID: 28100622 [TBL] [Abstract][Full Text] [Related]
26. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice. Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133 [TBL] [Abstract][Full Text] [Related]
27. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection. Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756 [TBL] [Abstract][Full Text] [Related]
28. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies. Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855 [TBL] [Abstract][Full Text] [Related]
29. Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses. Koel BF; Mögling R; Chutinimitkul S; Fraaij PL; Burke DF; van der Vliet S; de Wit E; Bestebroer TM; Rimmelzwaan GF; Osterhaus AD; Smith DJ; Fouchier RA; de Graaf M J Virol; 2015 Apr; 89(7):3763-75. PubMed ID: 25609810 [TBL] [Abstract][Full Text] [Related]
30. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. Hong M; Lee PS; Hoffman RM; Zhu X; Krause JC; Laursen NS; Yoon SI; Song L; Tussey L; Crowe JE; Ward AB; Wilson IA J Virol; 2013 Nov; 87(22):12471-80. PubMed ID: 24027321 [TBL] [Abstract][Full Text] [Related]
31. Hemagglutinin Stability Regulates H1N1 Influenza Virus Replication and Pathogenicity in Mice by Modulating Type I Interferon Responses in Dendritic Cells. Russier M; Yang G; Briard B; Meliopoulos V; Cherry S; Kanneganti TD; Schultz-Cherry S; Vogel P; Russell CJ J Virol; 2020 Jan; 94(3):. PubMed ID: 31694942 [TBL] [Abstract][Full Text] [Related]
32. A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity. Wang W; Castelán-Vega JA; Jiménez-Alberto A; Vassell R; Ye Z; Weiss CD Virology; 2010 Nov; 407(2):374-80. PubMed ID: 20869738 [TBL] [Abstract][Full Text] [Related]
33. A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge. Shoji Y; Jones RM; Mett V; Chichester JA; Musiychuk K; Sun X; Tumpey TM; Green BJ; Shamloul M; Norikane J; Bi H; Hartman CE; Bottone C; Stewart M; Streatfield SJ; Yusibov V Hum Vaccin Immunother; 2013 Mar; 9(3):553-60. PubMed ID: 23296194 [TBL] [Abstract][Full Text] [Related]
34. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes. Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119 [TBL] [Abstract][Full Text] [Related]
35. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
36. Hemagglutinin 222D/G polymorphism facilitates fast intra-host evolution of pandemic (H1N1) 2009 influenza A viruses. Seidel N; Sauerbrei A; Wutzler P; Schmidtke M PLoS One; 2014; 9(8):e104233. PubMed ID: 25162520 [TBL] [Abstract][Full Text] [Related]
37. The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice. Forero A; Tisoncik-Go J; Watanabe T; Zhong G; Hatta M; Tchitchek N; Selinger C; Chang J; Barker K; Morrison J; Berndt JD; Moon RT; Josset L; Kawaoka Y; Katze MG J Virol; 2015 Dec; 90(5):2240-53. PubMed ID: 26656717 [TBL] [Abstract][Full Text] [Related]
38. Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017. Al Khatib HA; Al Thani AA; Yassine HM Arch Virol; 2018 Nov; 163(11):3035-3049. PubMed ID: 30066273 [TBL] [Abstract][Full Text] [Related]
39. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins. Clark AM; DeDiego ML; Anderson CS; Wang J; Yang H; Nogales A; Martinez-Sobrido L; Zand MS; Sangster MY; Topham DJ PLoS One; 2017; 12(11):e0188267. PubMed ID: 29145498 [TBL] [Abstract][Full Text] [Related]
40. Variation in the HA antigenicity of A(H1N1)pdm09-related swine influenza viruses. Khalil AM; Yoshida R; Masatani T; Takada A; Ozawa M J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33616517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]